Foldit players solved a decade-old protein puzzle in weeks

The structure of the M-PMV retroviral protease, an enzyme central to how a monkey AIDS-like virus matures and replicates, had eluded structural biologists for more than ten years. X-ray crystallography gave incomplete data, and the computer algorithms researchers used to infer 3D protein shapes from that data — exhaustive, brute-force searches through astronomical numbers of possible foldings — kept failing to converge on a plausible answer. Solving it mattered directly for AIDS drug design, since knowing the enzyme's shape reveals where a drug could bind and disable it.

The University of Washington's Center for Game Science had already built Foldit, an online game that let anyone manipulate a 3D protein model by hand, competing for score against other players and against the computer's own folding algorithm, Rosetta. Researchers who had run out of algorithmic options handed the unsolved M-PMV structure to Foldit's players as a puzzle, betting that human spatial intuition might succeed where automated search had not.

They turned the unsolved structure into a competitive game, letting players' 3D intuition and parallel human searches succeed where automated algorithms got stuck.

Game scoring gave instant feedback, making the abstract problem engaging.

Thousands of players explored solutions in parallel, far more than one algorithm.

Players' prior Foldit experience built intuition for protein folding.

Human 3D reasoning outperformed brute-force search on this task.

When algorithms stall, reframe the problem as a game to harness human spatial intuition at scale.

Foldit's Contenders team solved the M-PMV protease structure in about three weeks; the result was published with players as co-authors. The result became a landmark case for citizen science in molecular biology, demonstrating that non-expert human pattern recognition could outperform pure computation on certain structural problems, and Foldit has since been used on other unsolved protein and enzyme-design challenges by the same research group.